Microsoft Corporation (NASDAQ:MSFT) ended the last trading day at $53.07. Company weekly volatility is calculated as 2.43% and price to cash ratio as 4.10. Microsoft Corporation (NASDAQ:MSFT) showed a weekly performance of 2.00%.
Microsoft Corporation (NASDAQ:MSFT) has launched a tool that makes it easier to for its users to migrate from Evernote, as it seeks to bolster the userbase of its own note-taking service, OneNote.
On 11 March, DCT Industrial Trust Inc. (NYSE:DCT) shares advanced 2.12% and was closed at $38.14. DCT EPS growth in last 5 year was 29.00%. DCT Industrial Trust Inc. (NYSE:DCT) year to date (YTD) performance is 2.06%.
DCT Industrial Trust Inc. (NYSE:DCT) announced that Philip L. Hawkins, President and Chief Executive Officer, will present at the Citi 2016 Global Property CEO Conference. The presentation is scheduled for 8:10 a.m. ET on Monday, March 14, 2016.
Alcoa Inc. (NYSE:AA) shares moved down -0.73% in last trading session and ended the day at $9.52. AA Gross Margin is 19.80% and its has a return on assets of -1.10%. Alcoa Inc. (NYSE:AA) quarterly performance is 9.40%.
On 4 March, Alcoa Inc. (NYSE:AA) was recently awarded a five-year contract by the U.S. Army worth up to USD$50 million to develop lightweight, yet durable solutions for ground combat vehicles.
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) caters to the Healthcare space. Its weekly performance is -9.00%. On the last day of trading company shares ended up at $1.77. Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) distance from 50-day simple moving average (SMA50) is 9.91%.
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) had its target price cut by JMP Securities from $10.00 to $9.00 in a research report sent to investors on Wednesday morning, Analyst Ratings.Net reports. They currently have a market outperform rating on the stock.
bluebird bio, Inc. (NASDAQ:BLUE) caters to the Healthcare space. Its weekly performance is -11.52%. On the last day of trading company shares ended up at $48.22. bluebird bio, Inc. (NASDAQ:BLUE) distance from 50-day simple moving average (SMA50) is 31.41%.
bluebird bio, Inc. (NASDAQ:BLUE) announced that interim data from the ongoing Phase 2/3 Starbeam Study (ALD-102) for the treatment of cerebral adrenoleukodystrophy (CALD) will be presented in an oral presentation during the Clinical Trials plenary session on April 20, 2016 at the American Academy of Neurology (AAN) 2016 Annual Meeting. The meeting is being held April 15 – 21, 2016 in Vancouver, BC, Canada.
Leave a Reply